Schedule 13G ownership disclosure

CONCERT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 206022105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,199,775
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041885-19-000010
Form type
SC 13G/A
Filer
CONCERT PHARMACEUTICALS, INC.
CIK
CIK 1367920
Filed
Jan 30, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub